Specialty Pharmacy Videos

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses how stakeholder alliances benefit patients.
A look at last week's top stories in the world of pharmacy.
Ron Lanton III, Esq, president, True North Political Solutions, LLC, discusses how proposed legislations would affect pharmacy benefit manager relations with specialty pharmacies.
John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses how data connectivity is crucial for the specialty pharmacy industry.
Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the importance of specialty pharmacists becoming certified and how it improves the industry as a whole.
Joel Wright, chief executive officer, AllianceRx Walgreens Prime discusses how specialty pharmacies can leverage retail pharmacies connections to negotiate costs.
Moses Zonana, CEO of Compliance Meds Technologies, discusses the impact of medication nonadherence.
A look at last week's top stories in the world of pharmacy.

Peer Exchange

PEER EXCHANGE > Management of Chemotherapy-Induced Nausea and Vomiting
Lee S. Schwartzberg, MD; Dawn Dolan, PharmD, BCOP; Howard Levine, PharmD; Eric Roeland, MD; and Beth Eaby-Sandy, CRNP, OCN, review the role of 5-HT3 receptor antagonists in treating chemotherapy-induced nausea and vomiting in moderately emetic chemotherapy.
PEER EXCHANGE > Management of Chemotherapy-Induced Nausea and Vomiting
In this segment, Lee S. Schwartzberg, MD; Beth Eaby-Sandy, CRNP, OCN; Howard Levine, PharmD; Eric Roeland, MD; and Dawn Dolan, PharmD, BCOP, share their views on whether or not to treat chemotherapy-induced nausea and vomiting due to immunotherapy and targeted therapy.
PEER EXCHANGE > Management of Chemotherapy-Induced Nausea and Vomiting
Dawn Dolan, PharmD, BCOP; Howard Levine, PharmD; Eric Roeland, MD; and Lee S. Schwartzberg, MD, provide insight on different patient education tools and modes of communication for the identification and treatment of chemotherapy-induced nausea and vomiting.
PEER EXCHANGE > Management of Chemotherapy-Induced Nausea and Vomiting
In this segment, Dawn Dolan, PharmD, BCOP; Beth Eaby-Sandy, CRNP, OCN; Eric Roeland, MD; and Lee S. Schwartzberg, MD, discuss patient risk factors to consider when treating chemotherapy-induced nausea and vomiting.

Insights

INSIGHTS > Sequencing of Therapy for Rheumatoid Arthritis
Stanley B. Cohen, MD, discusses the future treatment options for rheumatoid arthritis.
INSIGHTS > Sequencing of Therapy for Rheumatoid Arthritis
Stanley B. Cohen, MD, reviews the methodology, results, and clinical importance of the TEAR trial for rheumatoid arthritis.
INSIGHTS > Sequencing of Therapy for Rheumatoid Arthritis
Stanley B. Cohen, MD, describes the use of biologics to treat rheumatoid arthritis.
INSIGHTS > Sequencing of Therapy for Rheumatoid Arthritis
Stanley B. Cohen, MD, details the roles of both oral and subcutaneous methotrexate in the treatment of rheumatoid arthritis.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$